Obesity and the risk and prognosis of gallstone disease and pancreatitis
- 1 August 2014
- journal article
- review article
- Published by Elsevier in Best Practice & Research Clinical Gastroenterology
- Vol. 28 (4) , 623-635
Abstract
No abstract availableKeywords
Funding Information
- Italian Agency of Drug (MRAR08P011-2012)
- National Institutes of Health (DK73917)
This publication has 103 references indexed in Scilit:
- Current Views on Genetics and Epigenetics of Cholesterol Gallstone DiseaseCholesterol, 2013
- Population-based study of the need for cholecystectomy after obesity surgeryBritish Journal of Surgery, 2012
- Epidemiology of GallstonesGastroenterology Clinics of North America, 2010
- Targets for Current Pharmacologic Therapy in Cholesterol Gallstone DiseaseGastroenterology Clinics of North America, 2010
- Defective Hepatic Autophagy in Obesity Promotes ER Stress and Causes Insulin ResistanceCell Metabolism, 2010
- Nutrient sensing and inflammation in metabolic diseasesNature Reviews Immunology, 2008
- Pandemic obesity in EuropeBMJ, 2006
- Gallstone Formation Prophylaxis After Gastric Restrictive Procedures for Weight LossAnnals of Surgery, 2003
- Weight, Diet, and the Risk of Symptomatic Gallstones in Middle-Aged WomenNew England Journal of Medicine, 1989
- Effects of Ursodeoxycholic Acid and Aspirin on the Formation of Lithogenic Bile and Gallstones during Loss of WeightNew England Journal of Medicine, 1988